JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, vol.33, no.11, pp.1383-1390, 2020 (Journal Indexed in SCI)
Background: Sclerostin and osteoprotegerin (OPG) are new markers of chronic kidney disease (CKD) mediated mineral bone disease (CKD-MBD) which were extensively evaluated in adult population. We aimed to evaluate the associations between serum levels of sclerostin/OPG and parameters of bone turnover and compare the serum levels of sclerostin/OPG in different stages of CKD in children.